Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rovi CEO Scooping Up Shares Ahead of Earnings

Cable  TV software maker Rovi Corporation (NASDAQ:ROVI) doesn’t report Q2 earnings until July 30. But already, ahead of earnings, one shareholder is scooping up shares — Rovi’s own CEO.

This is according to a Form 4 filing on insider share purchases filed with the SEC yesterday, which confirms that on July 6, company CEO Tom Carson acquired 10,000 shares of Rovi at an average purchase price of $15.88 per share.

Should you do the same?

What does it mean to you?
The fact that Rovi’s own CEO is buying shares ahead of the company’s impending earnings report certainly sounds propitious for good news coming July 30. But before you assume an “earnings beat” is in the bag, consider: Carson’s purchase Monday amounts to a sizeable $158,000 investment. But even so, it’s just a fraction of the CEO’s $1.15 million annual salary. Nor do 10,000 shares move the needle much on Carson’s existing stake in the company, which was last reported at 238,493 shares.

All of which goes to show that despite the insider purchase, the CEO is still far from being “all in” on this stock. Before following his example, an investor should be aware of what could go wrong.

For example, although Rovi is expected to report strong earnings of $1.70 per share this year, the company is currently unprofitable over the last 12 months. Earnings expected out at the end of this month, too, will probably be down significantly from last year’s Q2. Analysts agree the company will likely report only $0.38 per share in profits for this year’s Q2, as opposed to the $0.43 earned in the year-ago quarter. Similarly, full-year profits are likely to be down year over year.

All that being said, the $1.70 that Rovi is expected to earn this year would give the stock a P/E ratio of less than 10. Relative to the company’s predicted long-term earnings growth rate of 13%, that doesn’t seem expensive. Perhaps, given the attractive valuation and the incremental positive of seeing the CEO buying, investors really should follow his example… by making an investment in Rovi — and making sure it’s a small investment — just in case.


This $19 trillion industry could destroy the Internet
One bleeding-edge technology is about to put the World Wide Web to bed. And if you act quickly, you could be among the savvy investors who enjoy the profits from this stunning change. Experts are calling it the single largest business opportunity in the history of capitalism… The Economist is calling it “transformative”… But you’ll probably just call it “how I made my millions.” Don’t be too late to the party — click here for one stock to own when the Web goes dark.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!